Log in to save to my catalogue

Enhancement of adenosine A2A signaling improves dopamine D2 receptor antagonist-induced dyskinesia v...

Enhancement of adenosine A2A signaling improves dopamine D2 receptor antagonist-induced dyskinesia v...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_89e64b3fef674dcab50c14b9ceb32b0b

Enhancement of adenosine A2A signaling improves dopamine D2 receptor antagonist-induced dyskinesia via β-arrestin signaling

About this item

Full title

Enhancement of adenosine A2A signaling improves dopamine D2 receptor antagonist-induced dyskinesia via β-arrestin signaling

Publisher

Frontiers Media S.A

Journal title

Frontiers in neuroscience, 2023-01, Vol.16, p.1082375-1082375

Language

English

Formats

Publication information

Publisher

Frontiers Media S.A

More information

Scope and Contents

Contents

Repeated administration of dopamine D
2
receptor (D2R) antagonists, which is the treatment for psychosis, often causes tardive dyskinesia (TD). Despite notable clinical demand, effective treatment for TD has not been established yet. The neural mechanism involving the hyperinhibition of indirect pathway medium spiny neurons (iMSNs) in the str...

Alternative Titles

Full title

Enhancement of adenosine A2A signaling improves dopamine D2 receptor antagonist-induced dyskinesia via β-arrestin signaling

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_89e64b3fef674dcab50c14b9ceb32b0b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_89e64b3fef674dcab50c14b9ceb32b0b

Other Identifiers

ISSN

1662-453X,1662-4548

E-ISSN

1662-453X

DOI

10.3389/fnins.2022.1082375

How to access this item